Table 6.
Baseline Correlates of Sexual Dysfunction§ among Female Participants (for adjusted and unadjusted logistic regression analyses)
| Unadjusted Model n=183 |
Adjusted Model 1 n=183 |
Adjusted Model 2 n=181 |
Adjusted Model 3 n=178 |
||||||
|---|---|---|---|---|---|---|---|---|---|
| Characteristic | Odds Ratio | 95% CI | Odds Ratio | 95% CI | Odds Ratio | 95% CI | Odds Ratio | 95% CI | |
| Unadjusted Model | |||||||||
| Systolic blood pressure (mmHg) | 0.997 | (0.98,1.02) | 0.995 | (0.97,1.02) | 0.996 | (0.97,1.02) | 1.008 | (0.98,1.04) | |
| Diastolic blood pressure (mmHg) | 0.985 | (0.96,1.01) | 0.992 | (0.96,1.03) | 0.988 | (0.95,1.03) | 0.987 | (0.94,1.03) | |
| Demographic Variables (Adjusted Model 1) | |||||||||
| Age (yrs). | --- | --- | 1.012 | (0.96,1.06) | 1.014 | (0.96,1.07) | 1.020 | (0.96,1.08) | |
| African-American vs. White | --- | --- | 0.713 | (0.34,1.50) | 0.662 | (0.30,1.46) | 1.328 | (0.52,3.42) | |
| Other vs. White | --- | --- | 0.983 | (0.42,2.30) | 0.821 | (0.33,2.03) | 1.649 | (0.54,5,03) | |
| < High school vs. College Graduate | --- | --- | 2.092 | (0.60,7.27) | 1.907 | (0.52,7.03) | 0.765 | (0.13,4.43) | |
| High School graduate/GED vs. College Graduate | --- | --- | 2.006 | (0.78,5.15) | 2.132 | (0.80,5.67) | 1.306 | (0.42,4.10) | |
| Post High School vs. College Graduate | --- | --- | 1.068 | (0.54,2.13) | 1.063 | (0.52,2.18) | 1.018 | (0.43,2.40) | |
| Lives alone vs. Lives with Others | --- | --- | 1.167 | (0.57,2.39) | 1.131 | (0.54,2.37) | 0.818 | (0.35,1.91) | |
|
Behavioral Risk Factor and Medication Use Variables (Adjusted Model 2) |
|||||||||
| Alcohol Consumption (drinks/typ wk) | --- | --- | --- | --- | 1.209 | (0.98,1.49) | 1.232 | (0.95,1.60) | |
| Beta-blockers (BB) vs. no BB | --- | --- | --- | --- | 0.820 | (0.39,1.71) | 0.809 | (0.34,1.92) | |
| Diuretics vs. no diuretics | --- | --- | --- | --- | 1.228 | (0.65,2.33) | 1.453 | (0.68,3.10) | |
| Calcium channel blockers vs.no calcium channel blockers |
--- | --- | --- | --- | 1.129 | (0.56,2.28) | 0.796 | (0.35,1.81) | |
| Angiotensin Converting Enzyme (ACE) inhibitors vs. no ACE |
1.604 | (0.78,3.30) | 2.003 | (0.84,4.76) | |||||
| Angiotensin receptor blockers (ARB) vs. no ARB | --- | --- | --- | --- | 1.658 | (0.75,3.68) | 2.188 | (0.88,5.46) | |
| Any Cholesterol Medication | --- | --- | --- | --- | 0.980 | (0.49,1.96) | 0.874 | (0.39,1.94) | |
|
Cardiometabolic and Psychosocial Variables (Adjusted Model 3) |
|||||||||
| BMI (kg/m2) | --- | --- | --- | --- | --- | --- | 0.947 | (0.89,1.01) | |
| eGFR (mL/min/1.73 m2) | --- | --- | --- | --- | --- | --- | 0.985 | (0.96,1.01) | |
| MoCA scoreas | --- | --- | --- | --- | --- | --- | 1.027 | (0.92,1.15) | |
| PHQ-9 Total Scoreb | --- | --- | --- | --- | --- | --- | 1.260 | (1.12,1.42) | |
| Number of Physical Comorbiditiesb | --- | --- | --- | --- | --- | --- | 1.234 | (1.03,1.48) | |
§
defined as Female Sexual Function Index (FSFI) score ≤26.55
--- variable not included in model
a
Higher scores indicate better function
b
Higher scores indicate poorer function significant (p<0.05) Adjusted Odds Ratios and 95% Confidence Intervals presented in bold